Racial disparities in pediatric injury hospitalization rates in a rural state
Methods: Injury rates were based on hospital discharge data (SD, 2009-2013) and diagnoses were coded according to ICD-9-CM codes (800-999).
Results: Injury hospitalization rates in 0-19 year olds increased from 21.9 to 31.2 per 10,000 between 2009 and 2013. Hospitalization rates of AI children were twice that of White children between 0-14 years (29.4/10,000 vs. 12.7/10,000) and three times higher for ages 15-19 years (112.9/10,000 vs. 39.1/10,000). Unintentional and suicide-related injuries were greater among AI children (26.2/10,000 & 15.6/10,000) than White children (13.2/10,000 & 5.2/10,000). Falls were the leading cause of hospitalization for AI and White children aged <10 years (7.3/10,000 vs. 3.4/10,000), while poisoning was the leading cause for AI and White children 10-19 years (24.5/10,000 vs. 9.3/10,000). Primary nature of injuries was fractures among both AI and White children aged 0-19 years (41.5% of hospitalizations) resulting primarily from unintentional injuries, with system-wide/late effects resulting from attempted suicide being second (30.6%).
Conclusions: South Dakota American Indian children have disproportionately higher hospitalization rates due to injuries. Knowing types of injuries requiring hospitalization will allow public health professionals to more efficiently target their efforts to prevent injuries.
Planning of health education strategies, interventions, and programs
Compare injury hospitalization rates by manner, mechanism and nature among South Dakota American Indian children to White children aged 0-19 years.
Keyword(s): Native Americans, Health Disparities/Inequities
Qualified on the content I am responsible for because: I have worked on projects with the South Dakota Department of Health evaluating racial disparities.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.